Navigation Links
Does Synthetic Biology Need Synthesized Ethics?
Date:6/24/2009

New Report Calls for a Broad Ethics of Emerging Technologies

WASHINGTON, June 24 /PRNewswire-USNewswire/ -- The emerging field of synthetic biology will allow researchers to create biological parts and systems that do not occur naturally as well as to re-engineer existing organisms to perform novel and beneficial tasks. As the science and its applications develop, a comprehensive approach to addressing ethical and social issues is called for, especially if scarce intellectual resources are to be used optimally, according to a new report authored by Erik Parens, Josephine Johnston, and Jacob Moses of The Hastings Center. Synthetic biology promises significant advances in areas such as biofuels, specialty chemicals, agriculture, and medicine but has also raised concerns about potential ethical, social, environmental, and security implications.

Commissioned by the Synthetic Biology Project at the Woodrow Wilson International Center for Scholars and supported by the Alfred P. Sloan Foundation, Ethical Issues in Synthetic Biology: An Overview of the Debates analyzes how the ethical issues raised by a variety of emerging technologies are often similar and familiar. The authors find that these similarities are abundant enough to justify an effort to develop an ethical framework that cuts across emerging and converging technologies. "Rather than stovepiping ethical questions into the hyphenated areas of bio-ethics, nano-ethics, neuro-ethics and so on, it is time to begin developing an ethics of emerging technologies as a whole," said Erik Parens in a discussion of the report's findings at the Woodrow Wilson Center on June 24.

"Given the rate at which new technologies are emerging, a comprehensive ethical approach should be developed to more readily identify and address ethical challenges and foster a productive public dialogue about social implications," said David Rejeski, director of the Synthetic Bi
'/>"/>

SOURCE Woodrow Wilson International Center for Scholars
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. CODA Genomics Announces Issuance of Optimized Synthetic Gene Production Patent
2. FDA Approves IXEMPRA(TM) (ixabepilone), a Semi-Synthetic Analog of Epothilone B, for the Treatment of Advanced Breast Cancer
3. Venter Institute Scientists Create First Synthetic Bacterial Genome
4. ES Vascular Receives CE Mark for its First Aortic Stapler for End-to-End Anastomosis Between Synthetic Grafts and Aorta During Open Repair of Aortic Aneurysmal and Occlusive Disease
5. WuXi PharmaTech Promotes Dr. Rujian Ma to VP of Synthetic Chemistry
6. The MathWorks Sponsors iGEM Competition for Synthetic Biology at MIT : MATLAB and SimBiology Help Accelerate Design of Synthetic Biological Systems
7. RNAi Helps Illuminate the Inner Workings of the Cell Cycle: Synthetic RNAissance™ Genes Created by DNA2.0 Enable Key Research
8. Synthetic Biology Importance in the 21st Century
9. Synthetic Biology: The Next Biotech Revolution Is Brewing
10. Pepscan Achieves a Breakthrough With CLIPS Immunogen Technology: Synthetic Peptide Antigen is Able to Induce Fully Functional Antibodies Against a Formerly Intractable GPCR Target CXCR7
11. Synthetic Biology on the Rise

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)... Dec. 3 ACCESS PHARMAC...ay provided an update on its European commercial l...l mucositis, a debilitating side effect of radiati...lly launched by Access, partner, SpePharm, in six ...ly, Norway, Greece and Sweden. Access is conductin...
(Date:12/3/2009)..., Dec. 3 Shire plc (LSE:...armaceutical company, today announced a voluntary ...l of one lot of the Attention-Deficit/Hyperactivit... taking this action because some Daytrana patches ...lease liner removal specification, and as a result...
(Date:12/3/2009)...s., Dec. 3 Inverness Med...ader in enabling individuals to take charge of the...nostics and health management, has declared a divi...e Perpetual Preferred Stock ( IMA-PB). The dividen...mount per share equal to the quotient of (a) $3.00...
(Date:12/3/2009)...EW DELHI, India, Dec. 3 /PRNewswire-Asia/ -- Dr. S...Shenzhen Beike Biotechnology Co. Ltd.,( http://www...h-Risk Diabetic,Foot Care in New Delhi, India, Nov... research and regenerative medicine company. ,,...atry Association (IPA), aimed,to help podiatrists ...
Breaking Biology Technology:Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 2Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 3Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 4Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 2Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 3Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 4Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 5Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 2Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 3
...LE, Md., Sept. 4 Human Genome,Sciences, Inc. (Nas... at the,BioCentury - Thomson Financial 14th Annive...e will be webcast and may be accessed at, http://w...-bin/prnh/20010612/HGSLOGO ) A member of Human G...t,an overview of the company on Thursday, Septembe...
...STER, Colo., Sept. 4 Allos,Therapeutics, Inc. (Na... on,the development and commercialization of small..., today announced that Paul L. Berns, President an...ar Stearns 20th Annual,Healthcare Conference in Ne...e at 9:00 a.m. (Eastern) on,Monday, September 10, ...
...reas Krause to Present on Statistical Consideratio...to Present on Modeling and Simulation ...lif., Sept. 4 Pharsight,Corporation (OTC Bulletin...strategic services for optimizing clinical drug de...cientists will deliver two presentations,to biopha...
Other Biology Technology:Allos Therapeutics to Present at the Bear Stearns 20th Annual Healthcare Conference 2Pharsight to Present at ROeS Seminar in Bern, Switzerland on September 10 & 11, 2007 2Pharsight to Present at ROeS Seminar in Bern, Switzerland on September 10 & 11, 2007 3
(Date:12/3/2009)...QUE, N.M. Most scientists believe that staph infe...nal each other to emit toxins. The signaling proce...must be present to start the process. , But the ...e very first stage of staph infection, when bacter...rs in a single cell and that this individual proce...
(Date:12/3/2009)... fish can undergo a personality change in warmer w...ing that climate change may make some species more...oung damselfish on Australia,s Great Barrier Reef ...are either consistently timid, or consistently bol...more marked as water temperatures rise. , A slig...
(Date:12/3/2009)...llers must be included in the design of the upcomi...umanitarian crisis, according to a scientist at th...re , Dr Simon Lewis argues that at least 50% of th...n, known as REDD (Reducing Emissions from Deforest...wellers directly, and their property rights assure...
Breaking Biology News(10 mins):Stopping MRSA before it becomes dangerous is possible, Sandia/UNM researchers find 2Stopping MRSA before it becomes dangerous is possible, Sandia/UNM researchers find 3Fish with attitude: Some like it hot 2Forest deal at Copenhagen must avoid creating 'carbon refugees' 2Gen Probe to Acquire Prodesse Leader in Molecular Testing for Respiratory Infectious Diseases for 2460 Million in Cash Plus Potential Milestone Pay 14377 1Gen Probe to Acquire Prodesse Leader in Molecular Testing for Respiratory Infectious Diseases for 2460 Million in Cash Plus Potential Milestone Pay 14377 2Gen Probe to Acquire Prodesse Leader in Molecular Testing for Respiratory Infectious Diseases for 2460 Million in Cash Plus Potential Milestone Pay 14377 3Gen Probe to Acquire Prodesse Leader in Molecular Testing for Respiratory Infectious Diseases for 2460 Million in Cash Plus Potential Milestone Pay 14377 4Gen Probe to Acquire Prodesse Leader in Molecular Testing for Respiratory Infectious Diseases for 2460 Million in Cash Plus Potential Milestone Pay 14377 5Medco Announces Date for Third Quarter 2009 Financial Results 3B Company to Provide 2010 Earnings Guidance 5273 1Medco Announces Date for Third Quarter 2009 Financial Results 3B Company to Provide 2010 Earnings Guidance 5273 2High sensitivity bone marrow aspiration technology enhances leukemia cell detection 58991 1High sensitivity bone marrow aspiration technology enhances leukemia cell detection 58991 2
... worlds leading STM publishers, will publish the J...l publication of the EUCC the Coastal Union. Lin...n to Springers other journals in coastal science, ...w and Marine Biology. The first issue of the rela... revised and broadened orientation and new subtitl...
...reporting what they say is a significant improveme...mouse cells to their embryonic state, a process th...c stem cells. , The finding, published on-line as...(Sept. 6, 2007), builds on the strategic breakthro... and confirmed in the spring of 2007 both by Yaman...
... Lodge, and Jennifer Hsia (University of Notre Dam... research communication, Failure of the Lacey Act ... The study appears in the September issue of Fron... 100 years on the books (passed in 1900), the Lace...nimal species. The injurious wildlife provision o...
Other Biology News:Springer will publish Journal of Coastal Conservation 2Embryonic stem cell strategy advanced with UCSF finding 2Embryonic stem cell strategy advanced with UCSF finding 3Embryonic stem cell strategy advanced with UCSF finding 4Examining the Lacey Act 2
NucBuster Protein Extraction Kit from Novagen
Goat IgG, Unconjugated from CHEMICON
DETACHaBEAD Mouse CD4 from Dynal Biotech
Rabbit anti-USP33 AbVantage Pack Polyclonal Antibody, Unconjugated from Bethyl Laboratories
Biology Products: